tc-99m teboroxime
Trade name: Cardiotec
Small moleculeapprovedImaging agent
Approved
Dec 19, 1990
Clinical trial activity
0 trials · 0 clinical orgs · 1 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
Indications
Approved for
Mechanism of action
- contrast mediumRadiopaque
contrast medium radiopaque
Approval history
- approvedPriority reviewDec 19, 1990
Chemistry & pharmacology
- Mol. weight
- 582.65 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Discontinued
- Imaging
- 99-technetiium
Oral
No
Parenteral
Yes
Topical
No
Sources
- ChEMBLCHEMBL2110653 ↗
- ChEMBLCHEMBL4597794 ↗
- ChEMBLCHEMBL4594222 ↗
- ChEMBLCHEMBL2104810 ↗
Also known as
- cardiotec
- cardiotec
- sq-30217
- tc-99m-sq-30217
- tc-99m-sq 30217 labeled
- tc-99m teboroxime
- tc-99m-teboroxime
- technetium (99mtc) teboroxime
- technetium cardiotec
- technetium sq 30217
- technetium tc 99m teboroxime
- technetium tc 99m teboroxime
- technetium tc99m teboroxime
- technetium tc-99m teboroxime kit
- technetium tc-99m teboroxime kit
- technetium teboroxime
- technetium teboroxime